Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v9-EN
Language English English
Date Updated 2017-03-30 2017-03-30
Drug Identification Number 01959018 01959018
Brand name MENOMUNE-A/C/Y/W-135 MENOMUNE-A/C/Y/W-135
Common or Proper name Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined
Company Name SANOFI PASTEUR LIMITED SANOFI PASTEUR LIMITED
Ingredients MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135 MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135 MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y
Strength(s) 50 μG 50 μG 50 μG 50 μG 50 μG 50 μG 50 μG 50 μG
Dosage form(s) Powder For Solution Powder For Solution
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 x 0.5 mL vial plus 1 x 0.6 mL diluent / 1 flacon de 1 dose de 0,5 mL et 1 flacon de 0,6 mL de diluant 1 x 0.5 mL vial plus 1 x 0.6 mL diluent / 1 flacon de 1 dose de 0,5 mL et 1 flacon de 0,6 mL de diluant
ATC code J07AH J07AH
ATC description BACTERIAL VACCINES BACTERIAL VACCINES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2017-03-28 2017-03-28
Actual discontinuation date 2017-03-28 2017-03-28
Remaining supply date 2017-03-28 2017-03-28
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Sanofi Pasteur has decided to discontinue the global supply production and commercialization of MENOMUNE®, its polysaccharide meningococcal vaccine. Sanofi Pasteur has decided to discontinue the global supply production and commercialization of MENOMUNE®, its polysaccharide meningococcal vaccine.
Health Canada comments